PNLIP and obesity due to melanocortin 4 receptor deficiency: By probing into the intricacies of inhibiting pancreatic lipase, assessing available treatments, confronting existing hurdles, and embarking on new explorations, this research domain endeavors to furnish a thorough insight into both the present and potential future of pancreatic lipase inhibition as a strategy for obesity treatment.